Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of candesartan cilexetil 16 mg tablets in healthy Thai volunteers
TCTR20161115002Phase 1Completed
- Sponsor
- International Bio Service
- Start
- May 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of candesartan cilexetil (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax, AUC0-tlast and 2 more. Started May 2017; status: completed.
02
Drugs
candesartan cilexetil
Beyond the preview
Go deeper on TCTR20161115002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161115002.